List of Omeprazole drug patents

Omeprazole is owned by Dexcel Pharma.

Omeprazole contains Omeprazole.

Omeprazole has a total of 3 drug patents out of which 0 drug patents have expired.

Omeprazole was authorised for market use on 04 December, 2007.

Omeprazole is available in tablet, delayed release;oral dosage forms.

The generics of Omeprazole are possible to be released after 08 December, 2036.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023391 DEXCEL PHARMA Stable benzimidazole formulation
Aug, 2025

(2 years from now)

US10076494 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(13 years from now)

US10835488 DEXCEL PHARMA Stable orally disintegrating pharmaceutical compositions
Dec, 2036

(13 years from now)

Drugs and Companies using OMEPRAZOLE ingredient

Market Authorisation Date: 04 December, 2007

Treatment: NA

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

OMEPRAZOLE family patents

8

United States

4

Israel

3

European Union

2

Australia

1

Germany

1

Austria

1

Canada

1

Spain

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in